Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Page 1
Monitoring for liver cancer post-gene therapy-How much and how often?
J Viral Hepat. 2024 Apr;31 Suppl 1:35-40. doi: 10.1111/jvh.13898.
J Viral Hepat. 2024.
PMID: 38606953
Review.
Hepatitis after gene therapy, what are the possible causes?
Maina A, Foster GR.
Maina A, et al.
J Viral Hepat. 2024 Apr;31 Suppl 1:14-20. doi: 10.1111/jvh.13919.
J Viral Hepat. 2024.
PMID: 38606951
Review.
Item in Clipboard
The benefits of gene therapy in people with haemophilia.
Thornburg CD.
Thornburg CD.
J Viral Hepat. 2024 Apr;31 Suppl 1:4-8. doi: 10.1111/jvh.13882.
J Viral Hepat. 2024.
PMID: 38606945
Review.
Item in Clipboard
Integration and the risk of liver cancer-Is there a real risk?
Kasimsetty A, Sabatino DE.
Kasimsetty A, et al.
J Viral Hepat. 2024 Apr;31 Suppl 1:26-34. doi: 10.1111/jvh.13915.
J Viral Hepat. 2024.
PMID: 38606944
Review.
Item in Clipboard
Which patients should be considered for gene therapy.
Miesbach W.
Miesbach W.
J Viral Hepat. 2024 Apr;31 Suppl 1:9-13. doi: 10.1111/jvh.13900.
J Viral Hepat. 2024.
PMID: 38606942
Review.
Item in Clipboard
The complex, confusing and poorly understood immune responses to AAV-mediated gene transfer in haemophilia-Is more or less immunosuppression required?
Tuddenham EGD, Foster GR.
Tuddenham EGD, et al.
J Viral Hepat. 2024 Apr;31 Suppl 1:21-25. doi: 10.1111/jvh.13934.
J Viral Hepat. 2024.
PMID: 38606938
Review.
Item in Clipboard
Cite
Cite